Identification of a Hydrogen-Sulfide-Releasing Isochroman-4-One Hybrid as a Cardioprotective Candidate for the Treatment of Cardiac Hypertrophy

Cardiac pathological hypertrophy is associated with undesirable epigenetic changes and causes maladaptive cardiac remodeling and heart failure, leading to high mortality rates. Specific drugs for the treatment of cardiac hypertrophy are still in urgent need. In the present study, a hydrogen-sulfide-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Liu, Yuechen, Wu, Hongyu, Xu, Shengtao, Ma, Fenfen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268299/
https://www.ncbi.nlm.nih.gov/pubmed/35807360
http://dx.doi.org/10.3390/molecules27134114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268299/
https://www.ncbi.nlm.nih.gov/pubmed/35807360
http://dx.doi.org/10.3390/molecules27134114

Ejemplares similares